Phase II study of early start of chemotherapy after excision of the primary colorectal cancer. (FUTURE 1102-Pearl star 02)
Phase 2
- Conditions
- Colorectal Cancer
- Registration Number
- JPRN-UMIN000006310
- Lead Sponsor
- Fukuoka Tumor Research(FUTURE)
- Brief Summary
https://www.ncbi.nlm.nih.gov/pubmed/29863132
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1.Prior severe drug allergy 2.Cavity fluid which needs drainage 3.Presence of active infection 4.Symptomatic brain metastases 5.Multiple malignancy within 5 years disease free interval 6.Uncontrolled hypertension 7.Uncontrolled diabetes 8.Peripheral nerve disorder 9.Severe pulmonary disease 10.Significant electrocardiographic abnormality 11.Treatment with anti-platelet drug 12.Chronic systemic treatment of corticosteroid 13.Nursing or pregnant females, or females or males with female partners who are planning to pregnancy 14.Inadequate for study enrollment by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy
- Secondary Outcome Measures
Name Time Method Response rate Time to treatment failure Overall survival Progression free survival Safety